Home / insider

Form 4 reporting owner · CIK 0002009762

Budur Kumar

CHIEF MEDICAL OFFICER

Dr. Budur has served as our Chief Medical Officer since May 2023. Previously, Dr. Budur was the Executive Medical Director at AbbVie Inc., a public biopharmaceuticals company, from August 2015 to February 2022. Prior to this, Dr. Kumar held positions of increasing responsibilities for six years at Takeda Pharmaceutical Company Limited, a global, research and development-driven pharmaceutical company. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of…

Biography from the company’s latest DEF 14A proxy statement

7Open-market trades
1Ticker
Avg 90d after buys
Avg 90d after sales
Avg 180d after buys
Avg 180d after sales

HRMY price and prints

Full HRMY chart

Harmony Biosciences Holdings, Inc. 7 open-market prints by this insider, 9/4/20269/18/2026. Triangles mark only their Form 4 purchases and sales.

HRMY adjusted close▲ buy▼ sale
38.0739.2740.4741.6642.862026-09-18 sell Budur Kumar2026-09-17 sell Budur Kumar2026-09-16 sell Budur Kumar2026-09-08 sell Budur Kumar2026-09-04 sell Budur Kumar2026-08-142026-09-18

HRMY trades

Clear
DateForm 4TickerSideSharesValue90d180d
9/18/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL35,852$1.54M
9/17/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL800$34.4K
9/16/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL1,800$77.4K
9/8/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL4,500$190.1K
9/8/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL1,000$42.8K
9/8/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL22,954$989.3K
9/4/2026
HRMYHarmony Biosciences Holdings, IncCHIEF MEDICAL OFFICER
Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90
SELL5,500$230.9K

Chart uses split-adjusted closes from the first print through the latest available bar. Returns use the last close on or before the trade date and the first close on or after 90 and 180 calendar days. Sales are signed so a declining price is a positive result for the seller. Not investment advice.